Axogen, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Scopelianos Angelo | Chief R&D Officer | Tax Withholding | 286 | $9.74 | $2,786 | 10,984 | Dec 27, 2021 |
| MARTINEZ MARIA D. | Chief Human Resources Officer | Tax Withholding | 286 | $9.74 | $2,786 | 5,731 | Dec 27, 2021 |
| MARIANI PETER J | EVP & Chief Financial Officer | Option Exercise | 2,625 | — | — | 24,794 | Dec 27, 2021 |
| Friedman Mark Louis | VP Regulatory Affairs & Policy | Tax Withholding | 286 | $9.74 | $2,786 | 17,452 | Dec 27, 2021 |
| Donovan Michael Patrick | VP Operations | Tax Withholding | 286 | $9.74 | $2,786 | 41,983 | Dec 27, 2021 |
| DeVinney Erick Wayne | VP Peripheral Nerve Science | Option Exercise | 750 | — | — | 87,436 | Dec 27, 2021 |
| Billet Isabelle | Chief Strategy and BD Officer | Tax Withholding | 326 | $9.74 | $3,175 | 14,184 | Dec 27, 2021 |
| Zaderej Karen L. | CEO | Tax Withholding | 1,243 | $9.24 | $11,485 | 923,029 | Dec 20, 2021 |
| MARIANI PETER J | EVP & Chief Financial Officer | Option Exercise | 1,900 | — | — | 22,926 | Dec 20, 2021 |
| Friedman Mark Louis | VP Regulatory Affairs & Policy | Tax Withholding | 95 | $9.24 | $878 | 16,588 | Dec 20, 2021 |
| Donovan Michael Patrick | VP Operations | Tax Withholding | 95 | $9.24 | $878 | 41,119 | Dec 20, 2021 |
| DeVinney Erick Wayne | VP Peripheral Nerve Science | Option Exercise | 575 | — | — | 86,830 | Dec 20, 2021 |
| DeVinney Erick Wayne | VP Peripheral Nerve Science | Tax Withholding | 4,171 | $8.80 | $36,705 | 86,255 | Dec 15, 2021 |
| Zaderej Karen L. | CEO | Option Exercise | 52,375 | $8.95 | $468,756 | 921,147 | Nov 24, 2021 |
| Zaderej Karen L. | CEO | Option Exercise | 46,500 | $3.67 | $170,655 | 868,772 | Aug 12, 2021 |
| Zaderej Karen L. | CEO | Sale | 2,083 | $19.16 | $39,910 | 814,018 | Aug 10, 2021 |
| Donovan Michael Patrick | VP Operations | Sale | 1,935 | $20.04 | $38,777 | 40,839 | Jul 21, 2021 |
| Sandberg Eric | Chief Commercial Officer | Award / Grant | 4,408 | — | — | 7,631 | Jul 20, 2021 |
| Scopelianos Angelo | Chief R&D Officer | Award / Grant | 2,572 | — | — | 10,757 | Jul 20, 2021 |
| MARTINEZ MARIA D. | Chief Human Resources Officer | Award / Grant | 2,572 | — | — | 5,504 | Jul 20, 2021 |
| Friedman Mark Louis | VP Regulatory Affairs & Policy | Award / Grant | 2,572 | — | — | 16,945 | Jul 20, 2021 |
| DeVinney Erick Wayne | VP Peripheral Nerve Science | Tax Withholding | 392 | $19.20 | $7,526 | 80,426 | Jul 19, 2021 |
| Donovan Michael Patrick | VP Operations | Tax Withholding | 637 | $19.20 | $12,230 | 42,774 | Jul 19, 2021 |
| Zaderej Karen L. | CEO | Tax Withholding | 8,812 | $19.20 | $169,190 | 780,018 | Jul 19, 2021 |
| MARIANI PETER J | EVP & Chief Financial Officer | Tax Withholding | 918 | $19.20 | $17,626 | 21,026 | Jul 19, 2021 |
| Billet Isabelle | Chief Strategy and BD Officer | Tax Withholding | 728 | $19.20 | $13,978 | 13,360 | Jul 19, 2021 |
| Freitag Gregory Gene | — | Option Exercise | 9,250 | $19.17 | $177,323 | 364,556 | Jun 17, 2021 |
| MARTINEZ MARIA D. | Chief Human Resources Officer | Sale | 2,652 | $18.86 | $50,017 | 2,932 | Jun 4, 2021 |
| Freitag Gregory Gene | — | Option Exercise | 24,000 | $3.67 | $88,080 | 355,306 | Jun 4, 2021 |
| Gold Mark Stephen | — | Option Exercise | 6,173 | — | — | 302,439 | Jun 1, 2021 |
| Wendell Amy McBride | — | Option Exercise | 6,173 | — | — | 32,097 | Jun 1, 2021 |
| Blackford Quentin S. | — | Option Exercise | 6,173 | — | — | 24,299 | Jun 1, 2021 |
| NEELS GUIDO J | — | Option Exercise | 6,173 | — | — | 48,764 | Jun 1, 2021 |
| Levine Alan M | — | Option Exercise | 6,173 | — | — | 8,764 | Jun 1, 2021 |
| Freitag Gregory Gene | — | Option Exercise | 15,000 | $5.45 | $81,750 | 281,306 | May 26, 2021 |
| NEELS GUIDO J | — | Option Exercise | 15,000 | $5.09 | $76,350 | 42,591 | May 19, 2021 |
| NEELS GUIDO J | — | Option Exercise | 15,000 | $5.09 | $76,350 | 42,591 | May 19, 2021 |
| DeVinney Erick Wayne | VP of Clin. & Trans. Sciences | Option Exercise | 10,000 | $2.86 | $28,600 | 78,082 | Apr 28, 2021 |
| Zaderej Karen L. | CEO | Option Exercise | 100,000 | $5.09 | $509,000 | 765,912 | Apr 16, 2021 |
| Zaderej Karen L. | CEO | Option Exercise | 34,500 | $3.67 | $126,615 | 665,912 | Mar 25, 2021 |
| Freitag Gregory Gene | — | Sale | 24,000 | $22.06 | $529,440 | 228,352 | Feb 25, 2021 |
| Donovan Michael Patrick | VP Operations | Sale | 1,808 | $19.15 | $34,623 | 40,839 | Feb 18, 2021 |
| Scopelianos Angelo | Chief R&D Officer | Award / Grant | 1,325 | — | — | 7,452 | Feb 17, 2021 |
| Friedman Mark Louis | VP, Regulatory & Quality | Award / Grant | 1,930 | — | — | 13,706 | Feb 17, 2021 |
| DeVinney Erick Wayne | VP, Clinical&Translational Sc | Award / Grant | 5,050 | — | — | 68,765 | Feb 17, 2021 |
| Donovan Michael Patrick | VP Operations | Award / Grant | 1,930 | — | — | 42,769 | Feb 17, 2021 |
| Freitag Gregory Gene | — | Award / Grant | 1,784 | — | — | 252,897 | Feb 17, 2021 |
| MARTINEZ MARIA D. | Chief Human Resources Officer | Award / Grant | 1,325 | — | — | 5,990 | Feb 17, 2021 |
| MARIANI PETER J | Chief Financial Officer | Award / Grant | 7,655 | — | — | 18,031 | Feb 17, 2021 |
| Sandberg Eric | Chief Commercial Officer | Tax Withholding | 903 | $18.70 | $16,886 | 3,223 | Feb 16, 2021 |